|Articles|January 10, 2023
Phastar Acquires S-Cubed ApS
Deal takes the Phastar group to around 550 people worldwide and strengthens the company's position in Nordic region.
Advertisement
Phastar announced the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Read more about the acquistion
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
